229 Deputy Jan O’Sullivan asked the Minister for Health and Children if she will exclude certain drugs from the reference pricing and generic substitution scheme when there is evidence that the generic does not have similar outcomes, including the proposed substitution of alendronate for the branded drugs Fosamax and Actonel, about which research is available on the website of the Irish Osteoporosis Society. [15910/10]

Summary

229 Deputy Jan O’Sullivan asked the Minister for Health and Children if she will exclude certain drugs from the reference pricing and generic substitution scheme when there is evidence that the generic does not have similar outcomes, including the proposed substitution of alendronate for the branded drugs Fosamax and Actonel, about which research is available on the website of the Irish Osteoporosis Society. [15910/10]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Generic Drugs.

  xml · EN · 20 April 2010

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.